Pharmaceutical manufacturer scaling digitalization and cloud infrastructure
HERMES Group is a mid-sized pharma manufacturer (1,001–5,000 employees, founded 1907) headquartered in Germany with active operations across manufacturing, sales, and quality assurance. The hiring surge in manufacturing (15 open roles) combined with accelerating Workday adoption and infrastructure cloud strategy suggests a shift toward modernizing legacy systems (Infor M3, on-premise LPLMS) while ramping production capacity. Quality and compliance digitalization appears critical: validation of computer-based systems and stability studies are live projects, and ensuring regulatory adherence is listed as a top pain point.
Notable leadership hires: Accounting Team Lead, Logistics Team Lead
HERMES Group manufactures pharmaceuticals and health products across four operating entities: HERMES ARZNEIMITTEL GmbH, HERMES PHARMA GmbH, Bad Heilbrunner Naturheilmittel GmbH & Co. KG, and HERMES Arzneimittel Holding GmbH. The company operates in Germany and Austria with a traditional manufacturing footprint underpinned by systems including Infor M3 (ERP), LIMS (lab data), and MES (production control). Current operational priorities center on quality process digitalization, accounting optimization, and cloud infrastructure strategy—a multi-year effort to balance legacy pharma operations with modern data and IT standards.
Core systems: Infor M3 (ERP), LIMS, MES, SQL, HPLC. Microsoft Office suite + Azure and AWS for cloud services. Adopting Workday for HR and finance automation.
Workday implementation, digitalization of quality processes, cloud and infrastructure strategy, accounting process optimization, computer system validation, and production stability and compliance initiatives.
Other companies in the same industry, closest in size